UnitedHealth Group Inc. - Q3 2003 10-Q Summary
Business Context and Reporting Period
This filing is a Quarterly Report (Form 10-Q) for UnitedHealth Group Inc. for the period ended September 30, 2003. The company operates through four primary segments: Health Care Services (UnitedHealthcare, Ovations, AmeriChoice), Uniprise, Specialized Care Services, and Ingenix. As of November 7, 2003, 586,643,108 shares of common stock were outstanding.
Key Financial Metrics
| Metric | Q3 2003 | Q3 2002 | 9M 2003 | 9M 2002 |
|---|---|---|---|---|
| Total Revenues | $7,238 million | $6,247 million | $21,300 million | $18,338 million |
| Net Earnings | $476 million | $353 million | $1,318 million | $973 million |
| Diluted EPS | $0.77 | $0.56 | $2.13 | $1.53 |
| Operating Cash Flow (9M) | $2,133 million (vs. $1,663 million in 2002) | |||
| Medical Care Ratio | 80.9% | 82.3% | 81.6% | 83.3% |
| Operating Margin | 10.5% | 9.2% | 10.0% | 8.6% |
| Total Debt (Carrying Value) | $1,750 million (Current: $350M; Long-term: $1,400M) | |||
| Cash & Investments | $6,954 million (Fair Value) |
Material Changes vs. Prior Period
- Revenue Growth: Consolidated revenues increased 16% year-over-year in Q3 2003, driven by premium rate increases, growth in individuals served, and acquisitions (specifically AmeriChoice).
- Profitability: Net earnings rose 35% year-over-year. Diluted EPS increased 38% to $0.77.
- Cost Efficiency: The medical care ratio improved to 80.9% from 82.3% in Q3 2002. This improvement was significantly aided by $100 million in favorable medical cost development (revisions to prior period estimates) in the quarter.
- Capital Structure: The company repurchased 29.4 million shares for approximately $1.4 billion during the first nine months of 2003. A 2-for-1 stock split was executed in June 2003.
Outlook, Risks, and Unusual Items
- Acquisitions:
- Mid Atlantic Medical Services (MAMSI): Agreed to acquire for approx. $2.65 billion (stock and cash); expected to close Q1 2004.
- GoldenRule Financial Corp: Agreed to acquire for approx. $500 million cash; closed November 2003.
- Legal Proceedings: The company is involved in consolidated class-action litigation (MDL No. 1334) regarding managed care practices. Consumer claims were dismissed in May 2003 following a settlement; provider claims remain pending. Management does not believe pending litigation will have a material adverse effect.
- Medical Cost Estimates: A critical accounting policy involves estimating medical costs payable. Favorable development of these estimates reduced reported medical costs by $100 million in Q3 2003. Excluding this, the medical care ratio was largely consistent with the prior year.
- Market Risk: A 1% change in interest rates would impact the fair value of fixed income investments by approximately $200 million.
Investor Verification Checklist
- Medical Cost Development: Verify the sustainability of the $100 million favorable cost development in Q3 2003 and its impact on the reported medical care ratio.
- Acquisition Integration: Monitor the closing and integration of the MAMSI and GoldenRule acquisitions and their impact on future leverage ratios.
- Share Repurchases: Confirm the remaining authorization for share repurchases (49.2 million shares as of Sept 30, 2003) and future buyback activity.
- Legal Exposure: Track the status of the health care provider track litigation in MDL No. 1334.
- Debt Covenants: Ensure continued compliance with the debt-to-total-capital ratio covenant (currently 26.9%, limit 45%).